|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Obesity | |||||
| Pre-Diabetes | |||||
| Insulin Resistance | |||||
| Impaired Glucose Tolerance | |||||
| Impaired Fasting Glucose | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Glucose Intolerance | |||||
| Prediabetic State | |||||
| 3 | More general conditions related to this trial | ||||
| Body Weight | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Hyperglycemia | |||||
| Hyperinsulinism | |||||
| Metabolic Diseases | |||||
| Nutrition Disorders | |||||
| Overnutrition | |||||
| Overweight | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Chromium | |||||
| 5 | More general drug interventions related to this trial | ||||
| Growth Substances | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Trace Elements | |||||
| 6 | Sponsors listed in this trial | ||||
| National Center for Complementary and Alternative Medicine (NCCAM) | |||||
| Yale University | |||||